Table 2.

Disease‐Specific Partner Services Costs and Outcomes, New York State, 2014

	HIV	Syphilis	Gonorrhea	Chlamydia	Total
Staff effortb, % of time spent per disease	11.5	9.8	28.4	50.3	100
Allocated program costc, $	789,949	667,897	1,943,675	3,448,541	6,850,063
Program outcomes (N)
Cases diagnosed	744	729	6,616	38,845	46,934
Index cases assigned	711	650	3,875	6,575	11,811
Index patients interviewed	491	623	3,199	5,432	9,745
Partners notified	408	703	1,909	2,841	5,861
Key performance indicatora	39	401	729	1,371	2,540
Cost metrics ($)
Cost per index case assigned	1,111	1,028	502	524	580
Cost per index case interview	1,609	1,072	608	635	703
Cost per partner notification	1,936	950	1,018	1,214	1,169
Cost per key performance indicator	20,255	1,666	2,666	2,515	2,697

Data sources: Program outcomes from HIV and STD statewide surveillance systems; staff effort estimate from mean effort allocation data (Martin et al. 2015); total program cost from statewide financial management, contract management, and human resource administration systems.

^aFor HIV, the key performance indicator represents notified partners found to be newly diagnosed HIV‐positive. Key performance indicators for syphilis, gonorrhea, and chlamydia represent the number of notified partners who were infected and brought to treatment, or preventively treated for exposure.

^bStaff effort represents the percentage of staff time devoted to each disease, based on the mean time to process each type of case (Martin et al. 2015) and the total number of cases processed during the year.

^cAllocated program area costs based on staff effort spent conducting disease investigations for each type of infection. This represents the percentage of total program costs ($6.85 million) spent on each disease. All costs are in $2014 and from the perspective of the New York State Department of Health's Division of HIV/STD/HCV Prevention.